Navigation Links
AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
Date:1/13/2010

WILMINGTON, Del., Jan. 13 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that enrollment and re-enrollment for two of its prescription savings programs is available online for the first time at www.azandme.com.

In addition, online self-service options are available for both programs, which enable health care providers, advocates and patients to order and monitor the shipping of refills and check the status of their enrollment online at www.azandme.com. AstraZeneca is the first pharmaceutical company to provide these self-service options directly to patients.

"We are using more tools to help patients get the medicines and information they need in an efficient and timely way," said Jennifer McGovern, AstraZeneca Director of Patient Assistance Programs. "We hope to be able to better serve patients and the people who support them by continually making program enhancements."

For over 30 years, AstraZeneca has offered patient assistance, because the company knows that medicines can only make a difference if patients can access them. Web-based improvements are another way that AstraZeneca is strengthening its commitment to patient health.

Program Details

To learn more about the program, get a list of available medicines, or to see if you qualify for an AZ&Me™ Prescription Savings program, please call  1-800-AZandMe (292-6363) or visit www.azandme.com. Assistance specialists are available Monday through Friday between 8 AM and 6 PM EST.

For those who prefer completing a hard-copy application, the AZ&Me™ Prescription Savings program for people without insurance and for people with Medicare Part D now also offers one streamlined application for both programs.  The application is available in English and Spanish at www.azandme.com or by calling 1-800-AZandMe (292-6363).

Prescription savings programs are available regardless of which medications doctors prescribe. To find out more about the more than 475 savings programs covering 2,500 medications, please visit www.pparx.org or call 1-888-4PPA-NOW (1-888-477-2669).

NOTES TO EDITORS:

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com.

SOURCE AstraZeneca

RELATED LINKS
http://www.astrazeneca-us.com

'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novexel to be Acquired by AstraZeneca
2. AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays
3. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
4. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
5. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
6. Jubilant Enters Research Collaboration With AstraZeneca
7. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
8. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
9. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
10. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
11. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... 2016 According to market ... Growth and Demand Forecast to 2022 - Industry ... Application (Drug Discovery and Development, Proteomics, Clinical Testing, ... Science and Biotechnology, Academic and Research Institute, Hospitals ... global mass spectrometry market was valued ...
(Date:5/23/2016)... 2016 Non-invasive diagnostic test realizes ... diseases; ,Technology to be presented at Yissum’s booth, at ... Development Company of the Hebrew University of Jerusalem ... with Aurum Ventures MKI, the technology investment arm of ... diagnostic approach for early detection of multiple diseases by ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... ... it will join America's leading engineers at the American Society of Safety Engineers ... World Congress Center. , Engineers, speakers and exhibitors from more than 40 ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... its inaugural health care blockchain event, Distributed: Health, to be held in Nashville, ... downtown Symphony Center. , A 24-hour Hackathon preceding the event will host teams ...
(Date:5/24/2016)... ... May 24, 2016 , ... i2i, a national leader in ... its “Transforming Outcomes” User Conference in Las Vegas on May 19-20, 2016. ... set the market standard for meaningful population health management. The company recently ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... Center at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The ... surgical services into a single site. , The new 2 story building houses ...
(Date:5/24/2016)... Irvine, CA — , ... ... the appointment of three new members of its Advisory Board. ... Chico and Sarah Kusch. “All three of them embody the mission ... team. We are very fortunate to have them as we continue ...
Breaking Medicine News(10 mins):